In type 2 diabetes with CKD and additional CV risk factors, sotagliflozin reduced total MACE vs. placebo at a median 14 mo.
Publication
, Journal Article
Thakkar, A; Newby, LK; ACP Journal Club Editorial Team at McMaster University
Published in: Ann Intern Med
June 2025
GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text] Endocrinology: [Formula: see text] Nephrology: [Formula: see text].
Duke Scholars
Published In
Ann Intern Med
DOI
EISSN
1539-3704
Publication Date
June 2025
Volume
178
Issue
6
Start / End Page
JC67
Location
United States
Related Subject Headings
- General & Internal Medicine
- 3202 Clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Thakkar, A., Newby, L. K., & ACP Journal Club Editorial Team at McMaster University. (2025). In type 2 diabetes with CKD and additional CV risk factors, sotagliflozin reduced total MACE vs. placebo at a median 14 mo. Ann Intern Med, 178(6), JC67. https://doi.org/10.7326/ANNALS-25-01791-JC
Thakkar, Aarti, L Kristin Newby, and ACP Journal Club Editorial Team at McMaster University. “In type 2 diabetes with CKD and additional CV risk factors, sotagliflozin reduced total MACE vs. placebo at a median 14 mo.” Ann Intern Med 178, no. 6 (June 2025): JC67. https://doi.org/10.7326/ANNALS-25-01791-JC.
Thakkar A, Newby LK, ACP Journal Club Editorial Team at McMaster University. In type 2 diabetes with CKD and additional CV risk factors, sotagliflozin reduced total MACE vs. placebo at a median 14 mo. Ann Intern Med. 2025 Jun;178(6):JC67.
Thakkar, Aarti, et al. “In type 2 diabetes with CKD and additional CV risk factors, sotagliflozin reduced total MACE vs. placebo at a median 14 mo.” Ann Intern Med, vol. 178, no. 6, June 2025, p. JC67. Pubmed, doi:10.7326/ANNALS-25-01791-JC.
Thakkar A, Newby LK, ACP Journal Club Editorial Team at McMaster University. In type 2 diabetes with CKD and additional CV risk factors, sotagliflozin reduced total MACE vs. placebo at a median 14 mo. Ann Intern Med. 2025 Jun;178(6):JC67.
Published In
Ann Intern Med
DOI
EISSN
1539-3704
Publication Date
June 2025
Volume
178
Issue
6
Start / End Page
JC67
Location
United States
Related Subject Headings
- General & Internal Medicine
- 3202 Clinical sciences
- 11 Medical and Health Sciences